The Globe and Mail reports in its Wednesday, Oct. 15, edition that BMO Capital Markets analyst Thanos Moschopoulos has reaffirmed his "outperform" recommendation for Celestica. The Globe's David Leeder writes in the Eye On Equities column that Mr. Moschopoulos's share target soared $70 to $300 (all figures U.S.). Analysts on average target the shares at $227.25. Mr. Moschopoulos says in a note: "We remain 'outperform' on Celestica and have raised our estimates and target price ahead of Q3/25 results, and following OpenAI's announcement of a strategic partnership with AVGO. We believe Celestica is likely to be a key beneficiary of OpenAI's AVGO-based spend, and that this isn't adequately reflected in current consensus estimates (particularly for FY2027, which we now focus on with respect to valuation). We believe the stock merits a premium multiple based on Celestica's customer experience." The Globe reported on Oct. 3 that TD Cowen analyst Daniel Chan had lowered his recommendation for Celestica to "hold" from "buy." The shares were then going for $233.67.
© 2025 Canjex Publishing Ltd. All rights reserved.